Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials

AS Antonopoulos, M Margaritis, R Lee… - Current …, 2012 - ingentaconnect.com
Ample evidence exists in support of the potent anti-inflammatory properties of statins. In cell
studies and animal models statins exert beneficial cardiovascular effects. By inhibiting …

Statins: could an old friend help in the fight against COVID‐19?

RR Rodrigues‐Diez, A Tejera‐Muñoz… - British journal of …, 2020 - Wiley Online Library
The COVID‐19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) has overwhelmed healthcare systems requiring the rapid development of …

Extracellular matrix molecules: potential targets in pharmacotherapy

H Järveläinen, A Sainio, M Koulu, TN Wight… - Pharmacological …, 2009 - ASPET
The extracellular matrix (ECM) consists of numerous macromolecules classified traditionally
into collagens, elastin, and microfibrillar proteins, proteoglycans including hyaluronan, and …

Pleiotropic Effects of Statins–Basic Research and Clinical Perspectives–

Q Zhou, JK Liao - Circulation journal, 2010 - jstage.jst.go.jp
Figure 2. Regulation of the Rho GTPase cycle. Rho protein cycle between an inactive GDP-
bound and an active GTP-bound state. Inhibition of the mevalonate synthesis by statins …

[HTML][HTML] Strategies for anti-fibrotic therapies

J Rosenbloom, FA Mendoza, SA Jimenez - Biochimica et Biophysica Acta …, 2013 - Elsevier
The fibrotic diseases encompass a wide spectrum of entities including such multisystemic
diseases as systemic sclerosis, nephrogenic systemic fibrosis and sclerodermatous graft …

Human fibrotic diseases: current challenges in fibrosis research

J Rosenbloom, E Macarak, S Piera-Velazquez… - Fibrosis: methods and …, 2017 - Springer
Human fibrotic diseases constitute a major health problem worldwide owing to the large
number of affected individuals, the incomplete knowledge of the fibrotic process …

Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases

SN Lin, R Mao, C Qian, D Bettenworth… - Physiological …, 2022 - journals.physiology.org
Intestinal fibrosis is considered an inevitable complication of Crohn's disease (CD) that
results in symptoms of obstruction and stricture formation. Endoscopic or surgical treatment …

Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions

S Kubota, M Takigawa - Clinical science, 2015 - portlandpress.com
CCN family protein 2 (CCN2), also widely known as connective tissue growth factor (CTGF),
is one of the founding members of the CCN family of matricellular proteins. Extensive …

Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms

L Liberale, F Carbone, F Montecucco… - The international journal …, 2020 - Elsevier
Chronic inflammation enhances the detrimental role of dyslipidaemia during atherogenesis.
Statins are among the most effective anti-atherosclerotic medications, being able to impact …

Anti-fibrotic effects of statin drugs: A review of evidence and mechanisms

DM Dolivo, CR Reed, KA Gargiulo… - Biochemical …, 2023 - Elsevier
Fibrosis is a pathological repair process common among organs, that responds to tissue
damage by replacement with non-functional connective tissue. Despite the widespread …